Role of FibroScan in evaluating hepatic involvement in systemic amyloidosis: a single‐centre prospective pilot study

Internal Medicine Journal · Published 2026-08-03 · DOI 10.1111/imj.70570

Free full text

Authors (10)

M Tang, N Vootukuru, J Tjahyadi, D Clayton Chubb, H Jina, SB Ting, S Bloom, R Sawhney, S Gibbs, O. Niewiadomski

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Tang, M., Vootukuru, N., Tjahyadi, J., et al. (2026). Role of FibroScan in evaluating hepatic involvement in systemic amyloidosis: a single‐centre prospective pilot study. Internal Medicine Journal. https://doi.org/10.1111/imj.70570

Related articles

• Regulatory standardisation to improve the safety of continuous glucose monitoring systems in Australia and New Zealand: joint ADS / ADEA / ADIPS / ANZSPED / NZSSD statement · Internal Medicine Journal · 2026 · Same journal
• Race‐neutral lung function equations and clinical interpretation in East Asian patients · Internal Medicine Journal · 2026 · Same journal
• Methodological considerations in the pre‐implementation evaluation of AI ‐guided surgical antimicrobial prophylaxis · Internal Medicine Journal · 2026 · Same journal
• Vitamin B6: too much, too little, too late? An analysis of sales trends in Australia from 2023 to 2025 · Internal Medicine Journal · 2026 · Same journal
• Assessing lung health disparities in Aboriginal Australians: inter‐community variation in spirometry pattern among adult Aboriginal people in rural and remote Australia · Internal Medicine Journal · 2026 · Same journal
• Improving primary aldosteronism diagnosis and treatment: outcomes from an endocrine hypertension service · Internal Medicine Journal · 2026 · Same journal
• Trustworthy artificial intelligence for rural health care · Internal Medicine Journal · 2026 · Same journal
• Unravelling the paradox of smoking cessation in multimorbidity: the roles of polypharmacy and treatment burden · Internal Medicine Journal · 2026 · Same journal
• Comparison of pharmacogenomic guidance in Australian prescribing resources and international pharmacogenomic guidelines · Internal Medicine Journal · 2026 · Same journal
• Complexity and comorbidities: critical considerations for methicillin‐resistant Staphylococcus aureus bacteraemia outcomes in the Northern Territory · Internal Medicine Journal · 2026 · Same journal